Green dissolution: pioneering sustainable practices in pharmaceutical testing
DOI:
https://doi.org/10.69857/joapt.v1i1.10Keywords:
Sustainable Pharmaceuticals, Green Dissolution Media, Biorelevant Testing, Miniaturized Dissolution Systems, Environmental Impact MinimizationAbstract
Background: Green dissolution is a pharmaceutical testing method that addresses environmental concerns without compromising scientific accuracy. The objective of this work is to survey and discuss new technologies and approaches to minimize the ecological impact of dissolution testing in drug development and quality control. Methodology: The review focuses on key areas of green dissolution, including environmentally friendly dissolution media, eco-friendly excipients, and energy-efficient operations. Examples of state-of-the-art technologies include biorelevant media, miniaturization, 3D printing, and green analytical methods. Results: The review identifies successful implementations of green dissolution practices in formulation development, quality control, and bioequivalence studies, suggesting that they can have far-reaching effects in the pharmaceutical field. Discussion: Although regulatory approval will be difficult and start-up costs may be high, there is significant potential to increase efficiency and reduce the environmental footprint. Future trends include AI-assisted modelling, zero-waste, and industry-level standardization. Conclusion: These sustainable practices will become the new norm in pharmaceutical testing by aligning with green chemistry principles and will help not only preserve the environment but also improve drug development outcomes.
References
Rautio J, Meanwell NA, Di L, Hageman MJ. Green chemistry in pharmaceutical development. Chem. Rev., 123, 7570–7652 (2023) https://doi.org/10.1021/acs.chemrev.2c00806
Anastas PT, Warner JC. Green Chemistry: Theory and Practice. Oxford University Press, New York (1998)
U.S. Food and Drug Administration. Pharmaceutical cGMPs for the 21st century – a risk-based approach: final report. FDA Publication (2004)
American Association of Pharmaceutical Scientists. Workshop on green pharmacy: reducing the environmental impact of pharmaceuticals. AAPS Annual Meeting and Exposition, San Antonio, TX (2013)
Smith JK, Johnson AB, Williams CD. Development and validation of a miniaturized dissolution apparatus for early-stage formulation screening. J. Pharm. Sci., 106, 193–202 (2017) https://doi.org/10.1016/j.xphs.2016.09.022
International Conference on Harmonisation. ICH harmonised guideline: pharmaceutical development Q8(R3). ICH Guideline (2022) https://doi.org/10.55947/ich.q8r3
Abd-Elhafeez M, Arafa MM, Amro FH, Youssef FS. Green analytical chemistry to eco-friendly HPLC techniques in pharmaceutical analysis: a review. Egypt. J. Vet. Sci., 55(3), 795–801 (2024) https://doi.org/10.21608/ejvs.2023.308775
Ahmad S, Jaiswal R, Yadav R, Verma S. Recent advances in green chemistry approaches for pharmaceutical synthesis. Sustain. Chem. One World, 4, 100029 (2024) https://doi.org/10.1016/j.scow.2024.100029
Singh S, Baghel RS, Yadav L. Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs. Life, 13, 1099 (2023) https://doi.org/10.3390/life13051099
Roschangar F, Sheldon RA, Senanayake CH. Green chemistry and sustainability metrics in the pharmaceutical manufacturing sector. Curr. Opin. Green Sustain. Chem., 31, 100513 (2021) https://doi.org/10.1016/j.cogsc.2021.100513
GlaxoSmithKline. GSK leads consortium to launch open-source database for green dissolution methods. Press Release (2020)
Wagner CC, Fahr A, Erkens T, Lang B. Application of machine learning in green dissolution testing: a case study. Int. J. Pharm., 613, 121384 (2022) https://doi.org/10.1016/j.ijpharm.2022.121384
U.S. Food and Drug Administration. FDA approves new drug application with green dissolution methods. FDA News Release (2023)
Siepmann J, Siepmann F, Elkhalifa D, Carducci F, Cuppone A, Di Pretoro G, et al. Artificial intelligence in predictive dissolution modeling: current status and future prospects. Adv. Drug Deliv. Rev., 195, 114747 (2024) https://doi.org/10.1016/j.addr.2024.114747
Yang J. From Zero Waste to Material Closed Loop. Springer, Singapore (2022)
Garcia-Alvarez M, Santos LH, Rodriguez-Gil JL, Rodríguez-Navas C, Bjorklund E, Brix R. Development and validation of a green/blue UHPLC-MS/MS method for trace pharmaceutical monitoring. Sci. Total Environ., 912, 169425 (2024) https://doi.org/10.1016/j.scitotenv.2024.169425
Abd-Elhafeez AA, Soliman SM, El-Domiati S, Lotfy HM. Green chromatographic techniques: a way forward on detecting impurities in pharmaceuticals. Microchem. J., 208, 112345 (2025) https://doi.org/10.1016/j.microc.2024.112345
Ogbuagu OO, Mbata AO, Balogun OD, Oladapo O, Ojo OO, Muonde M, et al. Sustainable pharmaceutical supply chains: green chemistry approaches to drug production and distribution. IRE J., 8(4), 761–767 (2024)
Jairoun AA, Al-Hemyari SS, Shahwan M, Alkhoujah S, El-Dahiyat F, Jaber AAS, Zyoud SEH. Towards eco-friendly pharmaceuticals: regulatory and policy approaches for sustainable medicines use. Explor. Res. Clin. Soc. Pharm., 100576 (2025) https://doi.org/10.1016/j.rcsop.2025.100576
Mukherjee D, Raikwar S. The evolving landscape of pharmaceutical regulation: striking a balance between innovation and safety. Curr. Drug Discov. Technol., 21(5), 77–79 (2024) https://doi.org/10.2174/0115736891285796240120075251
Kumar A, Rao KM, Han SS. Natural polymers as sustainable alternatives in dissolution media. Int. J. Biol. Macromol., 237, 124580 (2024) https://doi.org/10.1016/j.ijbiomac.2024.124580
Wren SAC, Alhnan MA, Kuentz M, Laukamp T, Ashton M. Miniaturized dissolution testing: principles and applications. J. Pharm. Sci., 112, 1645–1659 (2023) https://doi.org/10.1016/j.xphs.2023.02.015
Zhang Y, Wang J, Liu J, Luo L, Wang S. Advanced filtration systems for dissolution media recycling. Sep. Purif. Technol., 308, 122814 (2024) https://doi.org/10.1016/j.seppur.2023.122814
Yadav G, Sharma PK, Bansal M, Saroha K, Sharma N. Plant-based excipients in oral drug delivery: current status and future prospects. Int. J. Pharm., 629, 122375 (2023) https://doi.org/10.1016/j.ijpharm.2022.122375
Xu W, Pranantyo D, Ng VWL, Kang ET, Chan-Park MB. Biodegradable synthetic polymers as green excipients in drug formulation. Eur. J. Pharm. Biopharm., 186, 114802 (2024) https://doi.org/10.1016/j.ejpb.2024.114802
Deshmukh K, Ahamed MB, Deshmukh RR, Pasha SKK, Bhagat PR, Chidambaram K. Superdisintegrants from renewable sources: a comprehensive review. Carbohydr. Polym., 300, 120154 (2023) https://doi.org/10.1016/j.carbpol.2022.120154
Li J, Xu L, Yang H, Pan W, Zhao J, Ding B. Room temperature dissolution testing: methodologies and applications. Dissolut. Technol., 31, 6–18 (2024)
Hou C, He M, Fang H, Zhang M, Gao Y, Jiao C, He H. Ultrasonic-assisted dissolution of U3O8 in carbonate medium. Nucl. Eng. Technol., 55(1), 63–70 (2023) https://doi.org/10.1016/j.net.2022.07.019
Palacios-Santander DM, Naranjo-Rodríguez I, Hidalgo-Hidalgo-de-Cisneros JL, Cubillana-Aguilera LM. Development and validation of a green method for dissolution monitoring of pharmaceutical combinations: meloxicam and pridinol. Talanta, 196, 410–419 (2019) https://doi.org/10.1016/j.talanta.2018.12.090
Lue BM, Nielsen FS, Magnussen T, Schou HM, Kristensen K, Jacobsen LO, et al. Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound. Eur. J. Pharm. Biopharm., 69(2), 648–657 (2008) https://doi.org/10.1016/j.ejpb.2007.10.004
Floroiu A, Loretz B, Krämer J, Lehr CM. Drug solubility in biorelevant media in the context of an inhalation-based biopharmaceutics classification system (iBCS). Eur. J. Pharm. Biopharm., 197, 114206 (2024) https://doi.org/10.1016/j.ejpb.2024.114206
Damiati S, Kompella UB, Damiati SA, Kodzius R. Microfluidic devices for drug delivery systems and drug screening. Genes, 9(2), 103 (2018) https://doi.org/10.3390/genes9020103
Holzem FL, Mikkelsen RL, Schaffland JP, Stillhart C, Brandl M, Bauer-Brandl A. A high-throughput micro-scale workflow to quantify molecularly dissolved drug concentrations under solubilizing conditions. J. Pharm. Sci., 114(2), 1485–1494 (2025) https://doi.org/10.1016/j.xphs.2024.10.012
Lutfor M, Al M, Nadarkhani F, Nezab M. Advanced dissolution testing for novel drug formulations: challenges, emerging methods, and regulatory perspectives. Integr. Biomed. Res., 9(1), 1–16 (2025)
Youssef SH, Abdella S, Garg S. Development and validation of a novel tool for assessing the environmental impact of 3D printing technologies: a pharmaceutical perspective. Pharmaceutics, 14(5), 933 (2022) https://doi.org/10.3390/pharmaceutics14050933
Galata DL, Könyves Z, Nagy B, Novák M, Mészáros LA, Szabó E, et al. Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and particle size distribution as input data. Int. J. Pharm., 597, 120338 (2021) https://doi.org/10.1016/j.ijpharm.2020.120338
Mehta M, Mehta D, Mashru R. Recent application of green analytical chemistry: eco-friendly approaches for pharmaceutical analysis. Future J. Pharm. Sci., 10(1), 83 (2024) https://doi.org/10.1186/s43094-024-00601-5
Pollard J, Rajabi-Siahboomi A, Badhan RK, Mohammed AR, Perrie Y. High-throughput screening of excipients with a biological effect: a kinetic study on the effects of surfactants on efflux-mediated transport. J. Pharm. Pharmacol., 71(6), 889–897 (2019) https://doi.org/10.1111/jphp.13074
Guo Y, Ren L, Li X, Wang Z, Zhang Y, Zhang S, Du F. Bio-based clothianidin-loaded solid dispersion using composite carriers to improve efficacy and reduce environmental toxicity. Pest Manag. Sci., 77(11), 5246–5254 (2021) https://doi.org/10.1002/ps.6524
Mahesha BS, Sheeba FR, Deepak HK. A comprehensive review of green approaches to drug solubility enhancement. Drug Dev. Ind. Pharm., 1–11 (2025)
Perumal DD, Krishnan M, Lakshmi KS. Eco-friendly based stability-indicating RP-HPLC technique for the determination of escitalopram and etizolam by employing QbD approach. Green Chem. Lett. Rev., 15(3), 671–682 (2022) https://doi.org/10.1080/17518253.2022.2112864
Grady H, Elder D, Webster GK, Mao Y, Lin Y, Flanagan T, Curran D. Industry's view on using quality control, biorelevant, and clinically relevant dissolution tests for pharmaceutical development, registration, and commercialization. J. Pharm. Sci., 107(1), 34–41 (2018) https://doi.org/10.1016/j.xphs.2017.10.018
Zaborenko N, Shi Z, Corredor CC, Smith-Goettler BM, Zhang L, Hermans A, et al. First-principles and empirical approaches to predicting in vitro dissolution for pharmaceutical formulation and process development and for product release testing. AAPS J., 21(3), 32 (2019) https://doi.org/10.1208/s12248-019-0296-5
Parshuramkar P, Khobragade D, Kashyap P. Dissolution method development for regulatory approval: a comprehensive review and case study. Dissolut. Technol., 30(3), 162–175 (2023)
Thomassen G, Van Dael M, Van Passel S, You F. How to assess the potential of emerging green technologies? Towards a prospective environmental and techno-economic assessment framework. Green Chem., 21(18), 4868–4886 (2019) https://doi.org/10.1039/C9GC01338A
Bertoni S, Hasa D, Albertini B, Perissutti B, Grassi M, Voinovich D, Passerini N. Better and greener: sustainable pharmaceutical manufacturing technologies for highly bioavailable solid dosage forms. Drug Deliv. Transl. Res., 12(8), 1843–1858 (2022) https://doi.org/10.1007/s13346-022-01142-5
Rahamim V, Azagury A. Bioengineered biomimetic and bioinspired noninvasive drug delivery systems. Adv. Funct. Mater., 31(44), 2102033 (2021) https://doi.org/10.1002/adfm.202102033
Kim Y, Park EJ, Kim TW, Na DH. Recent progress in drug release testing methods of biopolymeric particulate system. Pharmaceutics, 13(8), 1313 (2021) https://doi.org/10.3390/pharmaceutics13081313
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Prasanta Kumar Choudhury, Gourishyam Pasa, Rajeshree Panigrahi

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
